Oxidative stress and gene expression in sepsis

British Journal of Anaesthesia

Volumn 90, Issue 2, 2003, Pages 221-232

  Macdonald, J ^a   Galley, H F ^a   Webster, N R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Infection, sepsis; Metabolism

Indexed keywords

21 AMINOSTEROID; 3,4 DIHYDRO 3,3 DIMETHYLISOQUINOLINE 2 OXIDE; ACETYLCYSTEINE; ALBUMIN; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; APOCYNIN; ASCORBIC ACID; AUTACOID; BACTERIUM LIPOPOLYSACCHARIDE; BETA CAROTENE; CHALCONE DERIVATIVE; DIHYDROXYCHLORODIHYDROCHALCONE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; ENDOTOXIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAZAROID; N TERT BUTYL ALPHA PHENYLNITRONE; NITRONE DERIVATIVE; PARACETAMOL; PLACEBO; PYRROLIDINE DITHIOCARBAMATE; SELENIUM; TEMPOL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BACTERIAL CELL WALL; CELL DAMAGE; CELL FUNCTION; CELL NUCLEUS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HOST CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; ORGAN INJURY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 0037311807     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg034     Document Type: Review

References (105)

1. Abate A, Schröder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-κB. Life Sci 1998; 62: 1081-8
2. Abraham E. NF-κB activation. Crit Care Med 2000; 28: N100-4
3. Angstwurm MWA, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27: 1807-13
4. Armour J, Tyml K, Lidington D, Wilson JX. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 2001; 90: 795-803
5. Arnalich F, Garcia-Palomero E, López J, et al. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68: 1942-5
6. Arrigo A-P. Gene expression and the thiol redox state. Free Radic Biol Med 1999; 27: 936-44
7. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-7
8. Barnes PJ. Nuclear factor-κB. Int J Biochem Cell Biol 1997; 29: 867-70
9. Basu S, Eriksson M. Vitamin E in relation to lipid peroxidation in experimental septic shock. Prostaglandins Leukot Essent Fatty Acids 2000; 62: 195-9
10. Batra S, Kumar R, Seema, Kapoor AK, Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Paediatr 2000; 20: 27-33
11. Ben-Shaul V, Lomnitski L, Nyska A, Zurovsky Y, Bergman M, Grossman S. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 2001 ; 123: 1-10
12. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17: 3-9
13. Blackwell TS, Yull FE, Chen C-L, et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 2000; 162: 1095-101
14. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996; 157: 1630-7
15. + channel in transmembrane signaling. J Immunol 2001; 166: 1009-15
16. Böhrer H, Qiu F, Zimmermann T, et al. Role of NFκB in the mortality of sepsis. J Clin Invest 1997; 100: 972-85
17. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55
18. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24: 392-7
19. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164: 4991-5
20. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-7
21. Carbonell LF, Nadal JA, Llanos MC, Hernández I, Nava E, Díaz J. Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit Care Med 2000; 28: 2002-6
22. Chang CK, Llanes S, Schumer W. Inhibitory effect of dimethyl sulfoxide on nuclear factor-κB activation and intercellular adhesion molecule 1 gene expression in septic rats. J Surg Res 1999; 82: 294-9
23. Chang CK, Albarillo MV, Schumer W. Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of nf-κB and AP-1 in septic rats. J Surg Res 2001; 95: 181-7
24. Chang CK, Llanes S, Schumer W. Effect of dexamethasone on NF-κB activation, tumour necrosis factor formation, and glucose dyshomeostasis in septic rats. J Surg Res 1997; 72: 141-5
25. Christman JW, Lancaster LH, Blackwell TS. Nuclear factor κB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 1998; 24: 1131-8
26. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systemic review of randomised controlled trials. BMJ 1998; 317: 235-40
27. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996; 24: 1179-83
28. Cuzzocrea S, Mazzon E, Dugo L, et al. Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J 2001; 15: 1187-200
29. Cuzzocrea S, McDonald MC, Mazzon E, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 2001; 29: 102-11
30. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and IFN regulatory factor 1 activation. J Immunol 1999; 162: 4685-96
31. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. J Clin Invest 1996; 98: 756-63
32. Downs TR, Dage RC, French JF. Reduction in endotoxin-induced organ dysfunction and cytokine secretion by a cyclic nitrone antioxidant. Int J Immunopharmacol 1995; 17: 571-80
33. Erl W, Weber C, Wardemann C, Weber PC. Alpha-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol 1997; 273: H634-40
34. Faure E, Thomas L, Xu H, Medvedev AE, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J Immunol 2001; 166: 2018-24
35. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 1998; 26: 1536-44
36. Fox ES, Brower JS, Bellezzo JM, Leingang KA. N-Acetylcysteine and α-tocopherol reverse the inflammatory response in activated rat Kupffer cells. J Immunol 1997; 158: 5418-23
37. Fujihara SM, Cleaveland JS, Grosmaire LS, et al. A D-amino acid peptide inhibitor of NF-κB nuclear localization is efficacious in models of inflammatory disease. J Immunol 2000; 165: 1004-12
38. Fukuma K, Marubayashi S, Okada K, Yamada K, Kimura A, Dohi K. Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice. Surgery 1999; 125: 421-30
39. Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-53
40. Galley HF, Webster NR. Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med 1996; 22: 226-9
41. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1996; 20: 139-43
42. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 1997; 23: 768-74
43. Galley HF, Webster NR. The immuno-inflammatory cascade. Br J Anaesth 1996; 77: 11-16
44. Gartner R, Angstwurm MW, Schottdorf J. Selenium administration in sepsis patients. Med Klin 1997; 92: 12-14
45. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51
46. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21: 1770-6
47. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999; 27: 922-35
48. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13: 85-94
49. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28
50. Gutteridge JMC, Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999; 55: 49-75
51. Handel ML, Watts CKW, deFazio A, Day RO, Sutherland RL. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc Natl Acad Sci USA 1995; 92: 4497-501
52. Huang YC, Guh JH, Cheng ZJ. Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells. Life Sci 2001; 68: 2435-47
53. Inohara N, Ogura Y, Chen FF, Muto A, Nuñez G. Human Nod 1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001; 276: 2551-4
54. Kheir-Eldin AA, Motawi TK, Gad MZ, Abd-ElGawad HM. Protective effect of vitamin E, β-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int J Biochem Cell Biol 2001; 33: 475-82
55. Kotake Y, Sang H, Miyajima T, Wallis GL. Inhibition of NF-κB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim Biophys Acta 1998; 1448: 77-84
56. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Free radical scavenging by lazaroids improves renal blood flow during sepsis. Surgery 1996; 120: 657-62
57. Krysztopik RJ, Matheson PJ, Spain DA, Garrison RN, Wilson MA. Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 2000; 93: 75-81
58. Lauzurica P, Martínez-Martínez S, Marazuela M, et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α. Eur J Immunol 1999; 29: 1890-900
59. Li N, Karin M. Is NF-κB the sensor of oxidative stress? FASEB J 1999; 13: 1137-43
60. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997; 159: 3976-83
61. Liu SF, Ye X, Malik AB. Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999; 55: 658-67
62. Liu SF, Ye X, Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999; 106: 1330-7
63. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001; 29: 870-7
64. Malmezat T, Breuillé D, Capitan P, Patureau Mirand P, Obled C. Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr 2000; 130: 1239-46
65. Marshall LF, Camp PE, Bowers SA. Dimethyl sulfoxide for the treatment of intracranial hypertension: a preliminary trial. Neurosurgery 1984; 14: 659-63
66. Meisner M, Schmidt J, Schywalsky M, Tschaikowsky K. Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock. Int J Immunopharmacol 2000; 22: 83-90
67. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-response factor. EMBO J 1993; 12: 2005-15
68. Mukaida N, Okamoto S, Ishikawa. Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56: 554-8
69. Mumby S, Margarson M, Quinlan GJ, Evans TW, Gutteridge JMC. Is bleomycin-detectable iron present in the plasma of patients with septic shock? Intensive Care Med 1997; 23: 635-9
70. Nathan AT, Singer M. The oxygen trail: tissue oxygenation. Br Med Bull 1999; 55: 96-108
71. Németh I, Boda D. Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome. Intensive Care Med 2001; 27: 216-21
72. Okada K, Marubayashi S, Fukuma K, Yamada K, Dohi K. Effect of the 21-aminosteroid on nuclear factor-κB activation of Kupffer cells in endotoxin shock. Surgery 2000; 127: 79-86
73. Opal SM. Selenium replacement in severe systemic inflammatory response syndrome. Crit Care Med 1999; 27: 2042-3
74. Ortolani O, Conti A, Raffaele de Gaudio A, Moraldi E, Cantini Q, Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161: 1907-11
75. Pascual C, Karzai W, Meier-Hellmann A, et al. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998; 26: 705-9
76. Paterson RL, Galley HF, Dhillon JK, Webster NR. Increased nuclear factor κB activation in critically ill patients who die. Crit Care Med 2000; 28: 1047-51
77. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor κB activation interleukin-6, interleukin-8 and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2002; in press
78. Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24: 1302-10
79. Peck MD, Alexander JW. Survival in septic guinea pigs is influenced by vitamin E, but not by vitamin C in enteral diets. JPEN J Parenter Enteral Nutr 1991; 15: 433-6
80. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JMC. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998; 95: 459-65
81. Rojas C, Cadenas S, Herrero A, Méndez J, Barja G. Endotoxin depletes ascorbate in the guinea pig heart. Protective effects of vitamins C and E against oxidative stress. Life Sci 1996; 59: 649-57
82. Salvo I, de Cian W, Musicco M, et al. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: S244-9
83. Sang H, Wallis GL, Stewart CA, Kotake Y. Expression of cytokines; and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl n-tert-butylnitrone (PBN). Arch Biochem Biophys 1999; 363: 341-8
84. Schlaak JF, Barreiros AP, Pettersson S, Schirmacher P, Meyer zum Büschenfelde KH, Neurath MF. Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogate fulminant septic shock induced by S. typhimurium in mice. Scand J Immunol 2001; 54: 396-403
85. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63: 760-5
86. Schow SR, Joly A. N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-incluced NF-κB activation and prevents TNF and IL-6 synthesis in vivo. Cell Immunol 1997; 175: 199-202
87. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-20
88. Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998; 113: 1616-24
89. Spapen H, Zhang H, Wisse E, et al. The 21-aminosteroid U74389G enhances hepatic blood flow and preserves sinusoidal endothelial cell function and structure in endotoxin-shocked dogs. J Surg Res 1999; 86: 183-91
90. Sprong RC, Aarsman CJM, van Oirschot JFLM, van Asbeck BS. Dimethylthiourea protects rats against Gram-negative sepsis and decreases tumor necrosis factor and nuclear factor κB activity. J Lab Clin Med 1997; 129: 470-81
91. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999; 26: 42-8
92. Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 1996; 21: 335-48
93. Suzuki YJ, Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem Biophys Res Commun 1993; 193: 277-83
94. Takeda K, Shimada Y, Amano M, et al. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 1984; 12: 957-9
95. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346: 547-52
96. Victor VV, Guayerbas N, Puerto M, Medina S, De la Fuente M. Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 2000; 46: 89-101
97. Villa P, Ghezzi P. Effect of N-acetyl-L-cysteine on sepsis in mice. Eur J Pharmacol 1995; 292: 341-4
98. Voehringer DW. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic Biol Med 1999; 27: 945-50
99. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. J Biol Chem 1995; 270: 9558-63
100. Webster NR, Nunn JF. Molecular structure of free radicals and their importance in biological reactions. Br J Anaesth 1988; 60: 98-108
101. Weinberg ED. Is bleomycin-detectable iron present in the plasma of patients with sepsis syndrome? Intensive Care Med 1997; 23: 613-14
102. White B, Schmidt M, Murphy C, et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000; 110: 130-4
103. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, Ferguson DA. Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1 → 3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 1999; 126: 54-65
104. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL. Protective effects of N-acetyl-L-cysteine in endotoxaemia. Am J Physiol 1994; 266: H1746-54
105. Zimmerman JJ. Defining the role of oxyradicals in the pathogenesis of sepsis. Crit Care Med 1995; 23: 616-17